Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Integrated BioPharma Inc. (INBP) had Revenue of $50.32M for the most recently reported fiscal year, ending 2024-06-30.

Quarterly Annual

Figures for fiscal year ending 2024-06-30

Income Statement Financials
Revenue	$50.32M
Net Income	$0.11M
Cost of Goods Sold	$46.43M
Gross Profit	$3.88M
Operating Expenses	$50.07M
Operating Income	$0.25M
Non-Operating Income/Expense	$0.02M
Pre-Tax Income	$0.27M
Normalized Pre-Tax Income	$0.27M
Income after Taxes	$0.11M
Income from Continuous Operations	$0.11M
Consolidated Net Income/Loss	$0.11M
Normalized Income after Taxes	$0.11M
EBIT	$0.25M
EBITDA	$1.47M
Weighted-Average Shares Outstanding (Basic)	30.07M
Weighted-Average Shares Outstanding (Diluted)	30.87M
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$17.88M
Property, Plant, and Equipment	$1.89M
Long-Term Assets	$8.33M
Total Assets	$26.21M
Current Liabilities	$6.12M
Long-Term Debt	--
Long-Term Liabilities	$0.85M
Total Liabilities	$6.97M
Common Equity	$19.24M
Tangible Shareholders Equity	$19.24M
Shareholders Equity	$19.24M
Common Shares Outstanding	30.10M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$0.94M
Cash Flow from Investing Activities	$-0.55M
Cash Flow from Financial Activities	$-0.03M
Beginning Cash	$1.32M
End Cash	$1.68M
Increase/Decrease in Cash	$0.36M
Stock-Based Compensation	$0.25M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.92
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	0.00
Gross Margin	7.72%
Operating Margin	0.50%
EBIT Margin	0.50%
EBITDA Margin	2.93%
Pre-Tax Profit Margin	0.53%
Profit Margin	0.22%
Free Cash Flow	$0.39M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.92
Inventory Turnover	4.13
Receiveable Turnover	10.78
Days Sales in Receivables	33.86
Return on Equity	0.58%
Return on Tangible Equity	0.58%
Return on Assets	0.43%
Return on Investments	0.58%
Book Value Per Share	$0.64
Free Cash Flow per Share	$0.01
Operating Cash Flow per Share	$0.03

Data from Zacks Investment Research, Inc.